Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
InpharmD logo — Clinicians ask questions. We provide customized, evidence-ba...

InpharmD

Clinicians ask questions. We provide customized, evidence-based, digital responses.

Founded 2018 United States Atlanta, United States 42 employees Total: $7.18M AI, Biotechnology +4

General Information

Company Name InpharmD
Founded Year 2018
Location United States Atlanta, United States
Founders / Decision Makers
Team member
Employees 42
Industries AI, Biotechnology, Health Care +3
Business Model B2B, SaaS, Platform
Revenue Model Subscription, Freemium, Tiered Pricing
Social

BounceWatch is an independent company data service, not affiliated with InpharmD. To contact InpharmD, visit inpharmd.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does InpharmD compare?

A PDF of InpharmD and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting InpharmD soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About InpharmD

InpharmD is a promising startup founded in 2018 that operates at the intersection of AI, Health Care, and Machine Learning. With its slogan, "Clinicians ask questions. We provide customized, evidence-based, digital responses," it captures its core mission succinctly.

The company is leveraging advanced technologies to enhance healthcare providers' access to high-quality information. Their platform connects clinical queries to tailored, evidence-based answers through a network of academic drug information centers. By optimizing this process with machine learning, InpharmD aims to facilitate better-informed decisions in healthcare.

Headquartered in the United States, InpharmD secured a $6.05M Seed Round investment on 07 December 2023 from notable investors including Y Combinator, Atlanta Ventures, 645 Ventures, ELC, and Qlarant Capital. This backing underscores substantial investor confidence in their innovative approach to healthcare.

Business keywords: digital health, healthcare providers, evidence-based, drug information, academic network, mobile application, health information, clinical decision-making, customized responses

Services & Products

Custom Literature Searches
Virtual Drug Information Support
Treatment Strategy Guidance

Target Customers

Clinical Pharmacists Healthcare Systems Medical Researchers

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Early VC $6.05M 1
645 Ventures
645 Ventures
01 Dec 2023
Early VC Undisclosed 1
Qlarant
Qlarant
01 Jan 2023
Seed $130.00K 1
Y Combinator
Y Combinator
01 Aug 2021
Seed Undisclosed -
01 Mar 2021
Seed $1.00M 1
Asymmetry Ventures
Asymmetry Ventures
01 Apr 2020
Spinout Undisclosed 1
University Ventures
University Ventures
01 Jan 2018

InpharmD Alternatives & Competitors

View All Alternatives
InpharmD vs
Doktorify
Doktorify Turkey

Your 24/7 AI-Powered Health Advisor

6 employees
AI, Health Care
Compare InpharmD vs Doktorify
InpharmD vs
NeuroReef Labs
NeuroReef Labs United States

Improve global well-being and healthcare by democratizing intelligent systems

Pre-Seed
16 employees
AI, Health Care
Compare InpharmD vs NeuroReef Labs
InpharmD vs
OrthoKeys
OrthoKeys Chile

Unlock Orthopedics

Venture round
2 employees
Care Economy, Health Care
View all alternatives

FAQ About InpharmD

Clinicians ask questions. We provide customized, evidence-based, digital responses.
InpharmD was founded in 2018.
InpharmD is headquartered in Atlanta, United States.
InpharmD operates in AI, Biotechnology, Health Care, Mobile, Pharmaceutical and Machine Learning. Its work centres on digital health, healthcare providers, evidence-based and drug information. Its customers include Clinical Pharmacists, Healthcare Systems and Medical Researchers.
InpharmD has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Freemium and Tiered Pricing.
InpharmD has approximately 42 employees.
InpharmD has completed 6 funding rounds, raising a total of $7.18M.
InpharmD offers: Custom Literature Searches, Virtual Drug Information Support, Treatment Strategy Guidance.
Top alternatives and competitors to InpharmD include Doktorify, NeuroReef Labs, OrthoKeys, Tuune, Pathway. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
InpharmD and Doktorify are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for InpharmD, https://bouncewatch.com/company/inpharmd, updated 22 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout